PanOptix lens safety confirmed years after surgery

NCT ID NCT06166901

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at the long-term safety and performance of AcrySof PanOptix trifocal lenses in 211 people who had them implanted in both eyes 3 to 5 years earlier. Researchers checked vision and recorded any eye problems or device issues. The goal was to make sure these lenses remain safe and effective over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APHAKIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Barraquer Ophthalmology Center

    Barcelona, 08021, Spain

  • Clinicas Novovision - Clinica Madrid

    Madrid, 28046, Spain

  • Hospital Arruzafa

    Córdoba, 14012, Spain

  • Hospital Universitari General de Catalunya

    Sabadell, Barcelona, 8205, Spain

  • Institut Catala de la Retina - Sarria

    Barcelona, 8022, Spain

  • Miranza IOA

    Madrid, 28033, Spain

  • Oftalvist Jerez - HLA Puerta del Sur

    Jerez de la Frontera, Cadiz, 11408, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.